Hung Nguyen, MD
Critical Care Medicine · Loma Linda, CANPI 1073532826
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.1%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by GSK at 42.2% of the total. Reporting peaked in 2021 at $18,881 and has fallen 99.2% since, to $145 in 2025. Among critical care medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 63 payments — averaging $488.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$13K
- Fisher Scientific Company L.L.C.$8K
- Cook Incorporated$6K
- La Jolla Pharmaceutical Company$3K
- AbbVie$492
- United Therapeutics Corporation$234
- plus $751 from 10 others
Across 1 payment — averaging $1560.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Octapharma USA, Inc.$2K
What the payments were for
- Consulting fees$13,00042%
- Speaking & faculty fees$15,73251%
- Travel & lodging$5142%
- Food & beverage$1,4775%
- Education$490%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 2 | $13,000 |
| Fisher Scientific Company L.L.C. | 3 | $7,585 |
| Cook Incorporated | 3 | $5,579 |
| La Jolla Pharmaceutical Company | 3 | $3,131 |
| AbbVie(2 entities) | 30 | $492 |
| United Therapeutics Corporation | 2 | $234 |
| Zimmer Biomet | 9 | $206 |
| Pulmonx Corporation | 1 | $130 |
| Actelion Pharmaceuticals US, Inc. | 1 | $125 |
| Merck | 1 | $125 |
| Masimo Corporation | 1 | $51 |
| Baxter Healthcare | 1 | $30 |
| Cook Medical LLC | 3 | $29 |
| Mallinckrodt Hospital Products Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $18 |
| Breathe Technologies, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Procalcitonin$7,500
- Blue Rhino$5,579
- GIAPREZA$3,082
- TYVASO$234
- CHARTIS CATHETER$130
- ZEPHYR DELIVERY CATHETER$130
- ZEPHYR ENDOBRONCHIAL VALVE$130
- PULMONX CHARTIS TABLET CONSOLE$130
- UPTRAVI$125
- OPSUMIT$125
- WINREVAIR$125
How this compares
$30,772 in reported general payments places this provider in the 95th percentile of 715 critical care medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Loma Linda
- Cedric Franklin RutlandRiverside$3.2M
- Chinh PhanSacramento$467K
- Timothy AlbertsonSacramento$418K
- Stephen ChenMonterey Park$394K
- Bassam YaghmourOrange$376K
- Xuanha WhiteSan Diego$343K
- Ken YonedaSacramento$173K
- Praveen AkuthotaSan Diego$169K
- Ivan ChengSan Francisco$162K
- Brian ShermanOxnard$147K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.